Pediatrix Medical (MD) Net Margin (2009 - 2026)
Pediatrix Medical's (MD) quarterly Net Margin came in at 8.17% in Q2 2026, down 21.0% year-over-year from 10.34% in Q2 2025, and up 31.53% quarter-over-quarter from 6.21% in Q1 2026.
Analysis
Pediatrix Medical (MD) Net Margin (2009 - 2026) Analysis & Trends
Pediatrix Medical (MD) has reported Net Margin for 18 consecutive years, with 8.17% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Net Margin fell 21.0% year-over-year to 8.17% in Q2 2026; TTM through Jun 2026 was 8.96%, a 330.0% increase from a year earlier, with the FY2025 full-year figure at 8.64%, up 1356.0% from the prior year.
- Net Margin was 8.17% for Q2 2026 at Pediatrix Medical, up from 6.21% in the prior quarter.
- Over five years, Net Margin peaked at 14.55% in Q3 2025 and troughed at 30.34% in Q2 2024.
- A 5-year average of 1.66% and a median of 5.62% in 2023 frame the typical range for Net Margin.
- Across the five-year window, Net Margin sank 3599 bps in 2024 and jumped 3872 bps in 2025, its largest moves.
- Over 5 years, Net Margin stood at 5.7% in 2022, then slumped by 540 bps to 25.04% in 2023, then surged by 124 bps to 6.07% in 2024, then gained by 12 bps to 6.82% in 2025, then increased by 20 bps to 8.17% in 2026.
- The last three Net Margin figures came in at 8.17% (Q2 2026), 6.21% (Q1 2026), and 6.82% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.76 Bn | 12.64 Bn | 1.16 Bn | 9.66% |
| 2 | RadNet | 5.80 Bn | 5.37 Bn | 88.08 Mn | 3.25% |
| 3 | Concentra Group Holdings Parent | 4.40 Bn | 4.26 Bn | 192.10 Mn | 11.10% |
| 4 | Privia Health | 2.61 Bn | 2.25 Bn | - | 1.54% |
| 5 | Pediatrix Medical | 2.20 Bn | 1.79 Bn | - | 8.17% |
| 6 | Fresenius Medical Care AG | 2.11 Bn | 1.41 Bn | 1.52 Bn | 4.49% |
| 7 | Progyny | 2.01 Bn | 1.77 Bn | 89.30 Mn | 8.00% |
| 8 | Surgery Partners | 1.87 Bn | 3.08 Bn | 622.10 Mn | 3.50% |
| 9 | U S Physical Therapy | 1.18 Bn | 1.47 Bn | 41.94 Mn | 6.96% |
| 10 | Starling Oncology | 595.78 Mn | 554.69 Mn | 27.17 Mn | -5.11% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.17% |
| Mar 31, 2026 | 6.21% |
| Dec 31, 2025 | 6.82% |
| Sep 30, 2025 | 14.55% |
| Jun 30, 2025 | 8.37% |
| Mar 31, 2025 | 4.52% |
| Dec 31, 2024 | 6.07% |
| Sep 30, 2024 | 3.80% |
| Jun 30, 2024 | -30.34% |
| Mar 31, 2024 | 0.81% |
| Dec 31, 2023 | -25.04% |
| Sep 30, 2023 | 4.22% |
| Jun 30, 2023 | 5.65% |
| Mar 31, 2023 | 2.89% |
| Dec 31, 2022 | 5.70% |
| Sep 30, 2022 | 6.27% |
| Jun 30, 2022 | 5.58% |
| Mar 31, 2022 | -4.39% |
| Dec 31, 2021 | 9.53% |
| Sep 30, 2021 | 6.25% |